SCHEMBL9196161

SCHEMBL9196161

c1ccc(-n2ccnc2)c(Cc2ccc3nccnc3c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.41
CYP3A4 P08684 5/20 0.40
CYP1A2 P05177 4/20 0.40
CYP2D6 P10635 4/20 0.40
CYP2C19 P33261 4/20 0.40
CYP2C9 P11712 3/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
TDP1 Q9NUW8 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 1/20 0.40
PMP22 Q01453 1/20 0.40
HTR5A P47898 1/20 0.40
GAA P10253 1/20 0.38
CYP11B1 P15538 4/20 0.38
CYP11B2 P19099 4/20 0.38
MET P08581 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8920154 0.86 NCOA3 (0.47) IDO1NCOA3CYP3A4CYP1A2CYP2D6
SCHEMBL7455193 0.82 IDO1 (0.39) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL7463718 0.82 NPC1 (0.44) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
Sulfuric Acid SCHEMBL9485614 0.81 NCOA3 (0.50) IDO1NCOA3HTR5ACYP11B1CYP11B2
SCHEMBL9077581 0.80 IDO1 (0.47) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL9836179 0.80 IDO1 (0.53) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL9195882 0.80 HTR5A (0.44) IDO1NCOA3CYP3A4CYP1A2CYP2D6
SCHEMBL9078567 0.79 FGFR1 (0.41) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL9524640 0.78 SLC9A1 (0.38) IDO1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL3279905 0.78 CTNNB1 (0.46) IDO1CYP3A4CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed